Michael Newman
Founder at INDAPTUS THERAPEUTICS, INC.
Net worth: 3 M $ as of 30/03/2024
Profile
Michael James Newman was the founder of Decoy Biosystems, Inc. (founded in 2013) and Indaptus Therapeutics, Inc. (founded in 2021), where he held the titles of President, CEO, CFO, Secretary & Director and Director & Chief Scientific Officer, respectively.
He previously worked as an Executive Director-Oncology at Novartis Pharmaceuticals Corp.
from 1992 to 1997, Senior Associate Director at Sandoz Pharmaceuticals Corp., Director & Chief Scientific Officer at Intec Pharma Ltd., Executive Vice President-Oncology at HUYA Bioscience International LLC and Ontogen Corp., Executive Vice President-Research & Development at Vaxiion Therapeutics, Inc., and Chief Scientific Officer & Vice President-Research at Dihedron Corp.
Dr. Newman was also a faculty member at Brandeis University from 1984 to 1987.
He received his undergraduate degree from the University of California San Diego and his doctorate from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INDAPTUS THERAPEUTICS, INC.
16.02% | 21/01/2024 | 1,368,356 ( 16.02% ) | 3 M $ | 30/03/2024 |
Michael Newman active positions
| Companies | Position | Start |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Founder | 23/02/2021 |
Former positions of Michael Newman
| Companies | Position | End |
|---|---|---|
Decoy Biosystems, Inc.
 Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Chief Executive Officer | 31/07/2021 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 31/12/1996 |
| Brandeis University | Corporate Officer/Principal | 31/12/1986 |
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Chief Tech/Sci/R&D Officer | - |
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Michael Newman
| University of California San Diego | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INDAPTUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Ontogen Corp. | |
| Sandoz Pharmaceuticals Corp. | |
Vaxiion Therapeutics, Inc.
 Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |
| Dihedron Corp. | |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
Decoy Biosystems, Inc.
Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Michael Newman
